Patent Assignment
Reel/Frame 054765/0791
Assignment of Assignor's Interest
Recorded: 2020-12-29
Pages: 4
Assignor
DURRANT, STEVEN JOHN
Executed: 2020-12-02
Assignee
VERTEX PHARMACEUTICALS (EUROPE) LIMITED
2 KINGDOM STREET, LONDON, W2 6BD, UNITED KINGDOM
Covered Properties
(2)
Substituted Tetrahydrofurans as Modulators of Sodium Channels
Patent:
11,834,441 →
Application:
17/112,156 →
Publication:
US 2021/0198241
PCT:
PCT/US2020/063290 ↗
Substituted Tetrahydrofurans as Modulators of Sodium Channels
Application:
62/944,869 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 29, 2020
From: VERTEX PHARMACEUTICALS (EUROPE) LIMITED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 054765/0730 →
Assignment of Assignor's Interest
Aug 24, 2022
From: DURRANT, STEVEN JOHN; SKERRATT, SARAH; PULLIN, ROBERT; ETXEBARRIA JARDI, GORKA
To: VERTEX PHARMACEUTICALS (EUROPE) LIMITED
Reel/Frame 060880/0678 →
Assignment of Assignor's Interest
Aug 24, 2022
From: VERTEX PHARMACEUTICALS (EUROPE) LIMITED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 060880/0873 →
Assignment of Assignor's Interest
Aug 24, 2022
From: THOMSON, STEVEN ANDREW; CARVALHO MEIRELES, LIDIO MARX
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 060880/0445 →
Assignment of Assignor's Interest
Aug 29, 2022
From: VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 060928/0958 →
Assignment of Assignor's Interest
Aug 29, 2022
From: STAMOS, DEAN; SCHMIDT, YVONNE; PONTILLO, JOSEPH; HADIDA RUAH, SARA S
To: VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
Reel/Frame 060928/0812 →
Assignment of Assignor's Interest
Nov 1, 2022
From: THOMSON, STEPHEN ANDREW; CARVALHO MEIRELES, LIDIO MARX
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 061608/0926 →
Assignment of Assignor's Interest
Nov 1, 2022
From: DURRANT, STEVEN JOHN; SKERRATT, SARAH; PULLIN, ROBERT; ETXEBARRIA JARDI, GORKA
To: VERTEX PHARMACEUTICALS (EUROPE) LIMITED
Reel/Frame 061609/0154 →
Assignment of Assignor's Interest
Nov 1, 2022
From: VERTEX PHARMACEUTICALS (EUROPE) LIMITED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 061609/0208 →